In some clinical trials, aromatase inhibitors have been used to treat prostate hypertrophy; some success was reported in men with complex partial epilepsy treated using this drug and other aromatase inhibitors [178, 179, 180]. The gene discussed is CYP19A1; the disease is benign prostatic hyperplasia.